Look for:

Products

FRESENIUS SE & CO. KGAA


ISIN:
DE0005785604
WKN:
578560

2024/10/07 09:00:17
Price
33.91 EUR
Difference -0.12% (-0.04)

General attributes

ISINDE0005785604
SymbolFRE
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)19,105 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)33.55 EUR (3,000)
Ask (Ask size)34.24 EUR (3,000)
Open33.91 EUR
High33.91 EUR
Low33.91 EUR
Close (prev. day)33.95 EUR
VWAP33.27 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: FRESENIUS SE & CO. KGAAPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/10/07 09:00:17
Price
33.91 EUR
Difference -0.12% (-0.04)

General attributes

ISINDE0005785604
SymbolFRE
ExchangeLondon Stock Exchange European Trade Reporting
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)19,105 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)33.55 EUR (3,000)
Ask (Ask size)34.24 EUR (3,000)
Open33.91 EUR
High33.91 EUR
Low33.91 EUR
Close (prev. day)33.95 EUR
VWAP33.27 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+35.42%+22.12%-16.63%
Perf (abs.)+8.88+6.15-6.77
Beta0.550.620.73
Volatility20.0822.8327.92
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)34.06 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)33.67 EUR (10,794)
Ø price 100 days | Ø volume 100 days (pcs.)31.01 EUR (6,658)
Ø price 250 days | Ø volume 250 days (pcs.)28.35 EUR (14,383)
YTD High | date34.71 EUR (2024/09/13)
YTD Low | date24.48 EUR (2024/03/26)
52 Weeks High | date34.71 EUR (2024/09/13)
52 Weeks Low | date24.19 EUR (2023/10/31)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/10/0712:4533.88 EUR3.72691
Vienna Stock Exchange2024/10/0711:0033.74 EUR0.002
Tradegate2024/10/0712:4433.86 EUR0.8495
Stuttgart2024/10/0712:4533.88 EUR0.2069
SIX Swiss Exchange2023/02/1717:3529.00 EUR0.001
SIX Swiss Exchange2020/04/0105:5553.06 CHF0.001
Munich2024/10/0708:0333.60 EUR0.001
London Stock Exchange European Trade Reporting2024/10/0709:0033.91 EUR0.001
Hanover2024/10/0708:0233.55 EUR0.001
Hamburg2024/10/0708:1633.79 EUR0.001
Frankfurt2024/10/0710:0133.68 EUR0.014
FINRA other OTC Issues2024/09/2619:3337.35 USD0.013
Euronext Milan MTF Trading After Hours2024/09/1218:0732.73 EUR0.001
Euronext Milan MTF Global Equity Market2024/10/0417:4433.94 EUR0.001
Duesseldorf2024/10/0712:3133.87 EUR0.003
Berlin2024/10/0712:3433.89 EUR0.007

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=994&ID_TYPE_IMAGE_LOGO=2

Contact Details

FRESENIUS SE & CO. KGAA
- -
Else-Kröner-Strasse 1 - 61352 Bad Homburg
Telefon: +49-6172-608-0
Fax: +49-6172-608-2628
E-mail: pr-fre@fresenius.com

PDF Downloads

Company report: FRESENIUS SE & CO. KGAAPDF Download

Company Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Members of Management Board

Michael SenChairman of Managing Board
Michael MoserMember of Executive Committee
Pierluigi AntonelliMember of Executive Committee
Robert MöllerMember of Executive Committee
Sara Lisa HennickenMember of Executive Committee

Board of directors

Wolfgang KirschChairman of Supervisory Board
Christoph ZindelMember of Supervisory Board
Iris Löw-FriedrichMember of Supervisory Board
Michael AlbrechtMember of Supervisory Board
Bernd BehlertMember of Supervisory Board
Frauke LehmannMember of Supervisory Board
Grit GensterMember of Supervisory Board
Holger MichelMember of Supervisory Board
Konrad KölblMember of Supervisory Board
Michael DiekmannMember of Supervisory Board
Oscar Romero de PacoMember of Supervisory Board
Susanne ZeidlerMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.